MONO INSTITUTIONAL EXPERIENCE IN NON SMALL LUNG CANCER WITH EML4-ALK REARRANGEMENT

被引：0
|
作者：
Perez Mesa, Pablo Jose [1 ]
Guadalupe Pallotta, Maria [1 ]
De La Iglesia, Paola [2 ]
Lupinacci, Lorena [1 ]
Liliana Dalurzo, Mercedes [2 ]
机构：
[1] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Pathol, Buenos Aires, DF, Argentina
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 09期
关键词：
EML4-ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.29
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [1] EML4-ALK Translocation in Lung Cancer: An Institutional Clinical Experience
    Bertino, E. M.
    Zhao, W.
    Villalona-Calero, M.
    Otterson, G. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S532 - S532
  • [2] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
    Verzura, Maria
    Batagelj, Emilio
    Bagnes, Claudia
    Martin, Claudio
    Enrico, Diego
    Richardet, Eduardo
    De la Iglesia, Paola
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
  • [3] EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
    Martelli, Maria Paola
    Sozzi, Gabriella
    Hernandez, Luis
    Pettirossi, Valentina
    Navarro, Alba
    Conte, Davide
    Gasparini, Patrizia
    Perrone, Federica
    Modena, Piergiorgio
    Pastorino, Ugo
    Carbone, Antonino
    Fabbri, Alessandra
    Sidoni, Angelo
    Nakamura, Shigeo
    Gambacorta, Marcello
    Luis Fernandez, Pedro
    Ramirez, Jose
    Chan, John K. C.
    Grigioni, Walter Franco
    Campo, Elias
    Pileri, Stefano A.
    Falini, Brunangelo
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (02): : 661 - 670
  • [4] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Bilgin, Burak
    Sendur, Mehmet Ali Nahit
    Yucel, Sebnem
    Hizal, Mutlu
    Guner, Gurkan
    Akyurek, Nalan
    Erol, Cihan
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    Kilickap, Sadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
  • [5] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Burak Bilgin
    Mehmet Ali Nahit Şendur
    Şebnem Yücel
    Mutlu Hizal
    Gürkan Güner
    Nalan Akyürek
    Cihan Erol
    Muhammed Bülent Akıncı
    Didem Şener Dede
    Bülent Yalçın
    Sadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643
  • [6] Endometrial cancer with an EML4-ALK rearrangement
    Craig, Jeffrey W.
    Quade, Bradley J.
    Muto, Michael G.
    MacConaill, Laura E.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2018, 4 (04):
  • [7] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [8] The biology and treatment of EML4-ALK non-small cell lung cancer
    Sasaki, Takaaki
    Rodig, Scott J.
    Chirieac, Lucian R.
    Janne, Pasi A.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) : 1773 - 1780
  • [9] EML4-ALK fusion gene in non-small cell lung cancer
    Lei, Yu
    Lei, Yan
    Shi, Xiang
    Wang, Jingjing
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [10] EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer
    Wang, Zhijie
    Zhang, Xuchao
    Bai, Hua
    Zhao, Jun
    Zhuo, Minglei
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Wang, Shuhang
    Wang, Yuyan
    Wu, Yilong
    Wang, Jie
    ONCOLOGY, 2012, 83 (05) : 248 - 256
12345